Skip to main content
Acticor Biotech logo

Acticor Biotech — Investor Relations & Filings

Ticker · ALACT ISIN · FR0012519668 LEI · 969500K433EK1G89EV95 PA Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2024-04-15 Regulatory Filings
Country FR France
Listing PA ALACT

About Acticor Biotech

https://www.acticor-biotech.com

Acticor Biotech is a clinical-stage biopharmaceutical company that originated as a spin-off from the French National Institute of Health and Medical Research (INSERM). The company is dedicated to developing innovative treatments for thrombotic diseases, with a primary focus on the acute phase of ischemic stroke. Its lead drug candidate, glenzocimab, is a humanized monoclonal antibody fragment designed to target platelet glycoprotein VI (GPVI), a key receptor involved in thrombosis. The therapeutic approach aims to provide an effective anti-thrombotic effect to safely manage stroke patients without increasing the risk of bleeding, a significant complication associated with existing treatments.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated April 15, 2024, announcing that Acticor Biotech will present clinical results from its phase 2/3 ACTISAVE study at the ESOC 2024 conference in May 2024. It details the study, provides context on the drug glenzocimab, and includes company background and contact information. This is a general corporate announcement regarding upcoming scientific/clinical data presentation, not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed investor presentation (IP). Since it is an announcement about future data presentation and general corporate news, it fits best under the general Regulatory Filings/Announcements category (RNS) or potentially a specialized announcement if one existed, but RNS serves as the best fit for non-standard, timely corporate news releases that aren't explicitly covered by other codes.
2024-04-15 English
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Disclosure of the total number of voting rights and shares as of March 31, 2024" and explicitly references compliance with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority (AMF). This type of mandatory disclosure, detailing the total share capital and voting rights at a specific date, is a standard regulatory filing in France. It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since it is a specific regulatory disclosure that doesn't fit the other precise categories (like DIRS, MANG, or DVA which deals with *results* of votes), the most appropriate classification is the general regulatory filing category, RNS, as it is a mandatory public disclosure. However, upon reviewing the definitions, the content specifically relates to the total number of voting rights and shares, which is often a component of proxy statements or general corporate governance updates. Given the options, and since it is a formal disclosure of share structure/rights, it is closest to a general regulatory announcement (RNS) or potentially related to voting rights (DVA), but DVA is for *results* of votes. Since it is a mandatory disclosure of the total count of shares/rights, RNS is the best fit as a general regulatory filing.
2024-04-05 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 mars 2024" (Monthly information relating to the total number of voting rights and shares comprising the share capital as of March 31, 2024). It explicitly references Article 223-16 of the AMF General Regulation, which mandates the publication of the total number of shares and voting rights monthly. The content is a press release providing a table detailing the total shares and theoretical/real voting rights as of a specific date (31/03/2024). This type of mandatory disclosure regarding the capital structure and voting rights, especially when published monthly or periodically outside of major corporate events like AGMs or earnings, fits best under the category for notifications related to share capital changes or regulatory disclosures. While it relates to the capital structure, it is not a formal share issue/buyback (SHA/POS) but a mandatory disclosure of the current count. Given the options, this specific type of mandatory monthly disclosure about the total number of shares and voting rights is most closely related to capital structure reporting, but since there isn't a specific code for 'Monthly Voting Rights Disclosure', we must evaluate the closest fit. It is not an AGM-R, 10-K, ER, or IR. It is a regulatory disclosure concerning the share base. The closest relevant categories are SHA (Share Issue/Capital Change) or RNS (Regulatory Filings). Since this is a routine, mandated disclosure about the *current count* of shares/votes, and not an announcement of a *change* (like a new issue or buyback), it functions as a general regulatory update. However, in many classification schemes, mandatory disclosures about the share count are grouped with capital changes. Let's re-examine the definitions. It is not a DVA (Voting Results), but a statement of the *potential* votes. It is a specific regulatory filing. Given the highly specific nature of the other codes, and the fact that this is a mandatory disclosure under AMF rules, RNS (Regulatory Filings - fallback) is a possibility, but let's check if it fits better elsewhere. It is not a DVA (Declaration of Voting Results), which relates to the outcome of a vote. It is a statement of the total shares. This is often classified as a 'Share Capital' update. Since 'SHA' is defined as 'Announcement regarding new share issues, stock splits, or other capital changes,' and this document reports the *current state* of the capital base following any changes, it is a strong candidate for a general capital structure report. However, because it is a routine, mandated disclosure (Article 223-16), it often falls under general regulatory announcements if a more specific code isn't available. Given the options, and recognizing this as a routine regulatory filing concerning the share base, RNS is the safest fallback, but let's consider if it implies a change. Since it reports the count as of a specific date, it is an update. If we interpret 'SHA' broadly as any official report on the share capital structure, it fits. If we strictly adhere to 'new share issues, stock splits, or other capital changes', it's borderline. Since it is a formal, mandated regulatory communication, RNS is the most appropriate general regulatory category when a specific 'Share Count Disclosure' code is missing. I will classify it as RNS as it is a routine regulatory filing mandated by the AMF.
2024-04-05 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Disclosure of the total number of voting rights and shares as of February 29, 2024" and explicitly references compliance with French Commercial Code and AMF regulations regarding the total number of shares and voting rights. This type of mandatory disclosure, detailing the capital structure and voting power as of a specific date, is a common regulatory filing requirement. It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). While it relates to capital structure, it is a specific regulatory disclosure about share count rather than a general financing announcement (CAP) or a transaction in own shares (POS). The closest fit among the provided options for a mandatory disclosure about the composition of share capital and voting rights is often categorized under general regulatory announcements or specific share/capital change notifications. Given the focus on the total number of voting rights and shares, it aligns most closely with a notification related to share capital structure, but since it's a routine, periodic disclosure of share count, it fits best under the general regulatory filing category (RNS) or potentially a specific share announcement (SHA). However, since it is a formal disclosure of the total number of shares and voting rights as mandated by law (Article L. 233-8 II of the French Commercial Code), it is a specific regulatory filing. Since there is no specific code for 'Total Voting Rights Disclosure', RNS (Regulatory Filings) serves as the appropriate fallback for mandatory, non-financial periodic disclosures that don't fit other specific categories like DIRS or DIV. The document is short and is a direct disclosure, not an announcement of a larger report.
2024-03-18 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 29 février 2024" (Monthly information relating to the total number of voting rights and shares comprising the share capital as of February 29, 2024). It explicitly references Article 223-16 of the General Regulation of the Autorité des Marchés Financiers (AMF) and provides a table detailing the total number of shares and voting rights as of a specific date. This type of mandatory periodic disclosure regarding the capital structure and voting rights is a specific regulatory filing requirement in France. While it is a regulatory announcement, it is not a general 'Regulatory Filing' (RNS) or a report like 10-K or IR. It specifically relates to the composition of capital and voting rights, which is often categorized under general corporate actions or specific regulatory disclosures. Given the options, this is a specific regulatory disclosure about the share capital structure. Since there is no direct code for 'Share Capital/Voting Rights Disclosure', and it is a formal, periodic regulatory communication, it fits best under the general 'Regulatory Filings' (RNS) category as a mandatory disclosure that doesn't fit the other specific financial report types (ER, IR, 10-K) or corporate action types (CAP, SHA, DIV). However, upon re-evaluating the definitions, this is a mandatory disclosure about the structure of the company's equity and voting rights, which is a fundamental corporate structure update. It is not a dividend (DIV), share issue (SHA), or transaction in own shares (POS). It is a formal regulatory communication. Given the options, RNS is the most appropriate fallback for a mandatory regulatory disclosure not covered elsewhere.
2024-03-18 French
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 98% confidence The document is a press release dated March 15, 2024, announcing the successful completion of a capital increase ('augmentation de capital') for a total amount of 8 million euros through the issuance of new shares. The key focus is on financing activities, the price of the new shares, the allocation to different investor categories (Reserved Offering, PrimaryBid), and the intended use of the funds (Phase 2/3 study continuation). This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report publication (RPA), as it contains the substantive details of the financing event itself.
2024-03-15 French

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.